Fundraisers

LSP closes latest fund

The Amsterdam, Netherlands-based manager has raised one of the largest life sciences funds.

11 March 2020

Fund name: Life Sciences Partners VI (LSP 6)
Amount raised: $600 million
Target size: $450 million
Hard-cap: $600 million
Stage of fundraising: Final close
Final close date: March 2020
Predecessor fund: Life Sciences Partners V (LSP 5) ($280 million)

Life Science Partners has closed its latest fund at its $600 million hard-cap. Life Sciences Partners VI (LSP 6) will follow the investment strategy of its predecessor funds investing in 15-18 predominantly European private companies developing new medications or medical technologies.

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Nearly there!

PODCAST: Dechert’s PE co-head on the biggest trends in the industry

Side Letter: Oakley’s multi-billion raise; LPs’ negotiating power; GP NAV delays

PE fundraising falls by more than $100bn amid investor crunch

Side Letter: Ham Lane’s $20,000 token ticket; Brookfield’s niche secondaries approach

LSP closes latest fund

Nearly there!

PODCAST: Dechert’s PE co-head on the biggest trends in the industry

Side Letter: Oakley’s multi-billion raise; LPs’ negotiating power; GP NAV delays

PE fundraising falls by more than $100bn amid investor crunch

Side Letter: Ham Lane’s $20,000 token ticket; Brookfield’s niche secondaries approach

Register now

Login

Sign in to your account